UbiVac Company
UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.
Technology:
CAR-T
Industry:
PharmTech
Headquarters:
Portland, Oregon, United States
Founded Date:
2005-01-01
Employees Number:
1-10
Total Funding:
2200000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-14
Last Funding Type:
Seed
Register and Claim Ownership